March 18 (Reuters) – Johnson & Johnson’s Stelara psoriasis drug has shown effectiveness against Crohn’s disease in a second late-stage trial, the company said on Friday, bolstering prospects of its…
The post UPDATE 1-J&J psoriasis drug Stelara eases Crohn’s disease in second trial appeared first on NASDAQ.